Equistasi® Equistasi®

Equistasi® clinical study accepted at the congress ISB/ASB 2019

HomeNewsEquistasi® clinical study accepted at the congress ISB/ASB 2019

The study “Effects of the Equistasi® neurological rehabilitation device on Parkinson’s disease patients” conducted by a team of professors and researchers at the University of Padua was accepted at the Congress of the International Society of Biomechanics (ISB/ASB 2019). It will convene in Calgary, Canada from July 31st to August 4th.

The trial was conducted by experts and specialists who have searched for effective treatments to this disorder for years. The work involved a team of researchers from the University of Padua, supported by Prof. Fabiola Spolaor and Dr. Daniele Volpe.

Parkinson’s disease is a progressive neurological condition characterized by tremors, rigidity, Brady kinesiology and gait problems, mainly arising from a dopamine deficiency. Gait disturbance is a key component of motor instability in PD patients. In particular, the gait cycle is influenced by rigidity, postural instability, and camptocormic posture; in people with Parkinson’s the stride and speed of the gait are decreased.

Thanks to the authors that represent us professionally – F. Spolaor, A.Guiotto, D.Pavan, L. Arab Yaghoubia, A.Peppe, P.Paone, Z.Sawacha, D.Volpe – Equistasi® will present its therapeutic approach and achievements to improve the quality of life for those affected by Parkinson’s disease.

The full text of this study can be found at Gaitposture.com or Researchgate.net.

Prendi un appuntamento

Contatta lo Staff di Equistasi® via email, telefonicamente o tramite form per ricevere assistenza e informazioni dettagliate sul prodotto e sulla terapia.

  • +39 02 95138354
  • info@equistasi.com
  • Compila il Form

Download

Download

Contact Us